Plain-English translation of NCT07311200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II clinical trial testing a new medication called to see if it can help people with active systemic lupus erythematosus (SLE). Researchers want to find out whether this treatment is safe and how well it works when taken daily over nearly a year. Half of the participants will receive the medication at different doses, and half will receive a placebo (a pill with no active ingredient) to compare results.
Lupus is a serious autoimmune disease that causes pain, inflammation, and damage to many parts of the body, and current treatments don't work well enough for everyone. This trial exists to see if this new treatment can help control active lupus symptoms and give patients a better option.
You likely qualify if…
You likely don't qualify if…
If you join, you'll first go through a screening period where doctors confirm you meet the study requirements. Then you'll be randomly assigned to take either the new medication or a placebo once daily for 48 weeks (nearly a year). You won't know which group you're in—neither will the researchers. Throughout the study, you'll have regular visits where blood samples are taken to check how the medication works and how it affects your body. After the 48 weeks of treatment, you'll have a follow-up period where researchers monitor your safety.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
InventisBio Co., Ltd
Enrollment target
~120 participants
Started
February 2026
Primary completion
August 2028
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hang Ren, Master
Zeng
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.